Abstract:Introduction: Adoption of allogeneic T cells directly supplements the number of T cells and rapidly induces T-cell immunity, which has good efficacy for treating some tumors and immunodeficiency diseases. However, poor adoptive T-cell engraftment and graft-versus-host disease (GVHD) limit the application of these methods. Alloreactive T-cell clones were eliminated from the donor T-cell repertoire, and the remaining T-cell clones were prepared as Tscm for T-cell adoptive treatment to reconstruct recipient T-cell immunity without GVHD. Methods: The subjects in this study included three different strains of mice. Lymphocytes from mice (C57BL/6) were used as the donor T-cell repertoire, from which the Tscm allo-reactive T cell clone was depleted (ATD-Tscm). This was confirmed by showing that the Tscm was not responsive to the alloantigen of the recipient (BALB/c). To prepare ATD-Tscm cells, we used recipient lymphocytes as a simulator, and coculture of mouse and recipient lymphocytes was carried out for 7 days. Sorting of non-proliferative cells ensured that the prepared Tscm cells were nonresponsive. The sorted lymphocytes underwent further expansion by treatment with TWS119 and cytokines for an additional 10 days, after which the number of ATD-Tscm cells increased. The prepared Tscm cells were transferred into recipient mice to observe immune reconstitution and GVHD incidence. Results: Our protocol began with the use of 1×107 donor lymphocytes and resulted in 1 ×107 ATD-Tscm cells after 17 days of preparation. The prepared ATD-Tscm cells exhibited a nonresponse upon restimulation of the recipient lymphocytes. Importantly, the prepared ATD-Tscm cells were able to bind long and reconstitute other T-cell subsets in vivo, effectively recognizing and answering the "foreign" antigen without causing GVHD after they were transferred into the recipients. Discussion: Our strategy was succeeded to prepare ATD-Tscm cells from the donor T-cell repertoire. The prepared ATD-Tscm cells were able to reconstitute the immune system and prevent GVHD after transferred to the recipients. This study provides a good reference for generating ATD-Tscm for T-cell adoptive immunotherapy.

Donor MHC-specific Thymus Vaccination for Immunocompatible Allotransplantation

An Efficient Combination Immunotherapy for Antitumor Immunity Without Accelerating Cardiac Allograft Rejection.

Regulatory T Cell Therapy for the Induction of Clinical Organ Transplantation Tolerance

Transfer of Multiple Loci of Donor's Genes to Induce Recipient Tolerance in Organ Transplantation.

Cardiac Allograft Tolerance Induced by Isogeneic CD4+CD25+ Regulatory T Cells.

A NOVEL STRATEGY FOR ORGAN ALLOGRAFTS USING SUBLETHAL (7 Gy) IRRADIATION FOLLOWED BY INJECTION OF DONOR BONE MARROW CELLS VIA PORTAL VEIN1

Donor-Specific Regulatory T Cells Acquired from Tolerant Mice Bearing Cardiac Allograft Promote Mixed Chimerism and Prolong Intestinal Allograft Survival

Donor Gene Transfecting Recipient to Induce Specific Immunological Tolerance

Donor Specific Tolerance for MHC Mis-Matched Murine Skin Allograft Induced by Donor Bone Marrow Transplantation with Precondition of High Dose Immunosuppressants

Negative Vaccination Strategies for Promotion of Transplant Tolerance

Study on Donor-Specific Antigens in Inducing Immunogical Tolerance

Introducing thymus for promoting transplantation tolerance

Tolerance Induction for Xenotransplantation

Toward transplantation tolerance with adipose tissue-derived therapeutics

An Immunotherapeutic Strategy for Prolonging Graft Survival in Mice.

IMMUNE MODULATION AND PREVENTION OF ALLOGENEIC GRAFT REJECTION BY THERAPEUTIC DENDRITIC CELLS:

Graft‐Versus‐Tumor Effect in Major Histocompatibility Complex–Mismatched Mouse Liver Transplantation

The Role Of Selective Depletion Of Alloreactive Donor T Cells In Graft-Versus-Host Disease After Allogeneic Bone Marrow Transplantation.

Rapamycin in Combination with Donor-Specific CD4+CD25+Treg Cells Amplified in Vitro Might Be Realize the Immune Tolerance in Clinical Organ Transplantation

A strategy to reconstitute immunity without GVHD via adoptive allogeneic Tscm therapy

Strategies to Achieve Immune Tolerance in Allogeneic Solid Organ Transplantation.